Biostar Pharmaceuticals, Inc. established an office in Gansu Province, PRC, on January 6, 2014 with the focus on the sales of Hepatitis B products in three provinces, including Gansu, Qinghai and Tibet. These three provinces are located in the western region of China where pharmaceutical products historically have shown a consistently good sales track record primarily due to the relatively poor medical condition and corresponding high incidence of Hepatitis B among the residents of these provinces. The company expects that in 2014, this newly opened sales office will contribute USD 4 million additional revenue of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000014 USD | -86.00% | -.--% | -86.00% |
1st Jan change | Capi. | |
---|---|---|
-86.00% | 36 | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- BSPM Stock
- News Biostar Pharmaceuticals, Inc.
- Biostar Pharmaceuticals, Inc. Opens Sales Office in Gansu Province, PrC